These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 17451183

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials in neuroprotection.
    Whitcup SM.
    Prog Brain Res; 2008; 173():323-35. PubMed ID: 18929119
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases.
    Nithianantharajah J, Hannan AJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):331-9. PubMed ID: 21112312
    [Abstract] [Full Text] [Related]

  • 5. Genetic mouse models of neurodegenerative diseases.
    Trancikova A, Ramonet D, Moore DJ.
    Prog Mol Biol Transl Sci; 2011 Mar 30; 100():419-82. PubMed ID: 21377633
    [Abstract] [Full Text] [Related]

  • 6. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA, Blezer EL, Jongsma MJ, Vanwersch RA, Olivier B, Philippens IH.
    Brain Res; 2008 Jan 16; 1189():219-28. PubMed ID: 18076869
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proton MRS of early post-natal mouse brain modifications in vivo.
    Larvaron P, Bielicki G, Boespflug-Tanguy O, Renou JP.
    NMR Biomed; 2006 Apr 16; 19(2):180-7. PubMed ID: 16470692
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Transgenic nonhuman primates for neurodegenerative diseases.
    Chan AW.
    Reprod Biol Endocrinol; 2004 Jun 16; 2():39. PubMed ID: 15200672
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic RNA interference for neurodegenerative diseases: From promise to progress.
    Gonzalez-Alegre P.
    Pharmacol Ther; 2007 Apr 16; 114(1):34-55. PubMed ID: 17316816
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
    Popovic N, Brundin P.
    Int J Pharm; 2006 May 18; 314(2):120-6. PubMed ID: 16529886
    [Abstract] [Full Text] [Related]

  • 15. Behavioral phenotyping of mouse models of neurodegeneration.
    Dumont M.
    Methods Mol Biol; 2011 May 18; 793():229-37. PubMed ID: 21913104
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H, Kopito RR.
    Nature; 2007 Aug 09; 448(7154):704-8. PubMed ID: 17687326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.